WELLS FARGO & COMPANY/MN
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,010,478
+$5,044,106 QoQ
Shares Held
72,147
+111.5% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 299 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. RYTM ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,010,478 | 72,147 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,966,372 | 34,108 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,772,923 | 72,617 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,760,062 | 47,134 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,677,233 | 42,368 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,741,693 | 70,638 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,089,397 | 37,324 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,544,142 | 29,474 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,212,704 | 29,535 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,169,259 | 26,985 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,827,720 | 39,759 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,231,277 | 53,709 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,271,279 | 77,094 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $906,324 | 50,803 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $196,355 | 6,743 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $53,263 | 2,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,050 | 8,928 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $113,103 | 9,818 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $211,006 | 21,143 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,900 | 2,213 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $191,315 | 9,771 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $448,009 | 21,063 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $929,983 | 31,281 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $368,931 | 17,025 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $479,583 | 21,506 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $228,513 | 15,014 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||